TG Therapeutics, Inc.

TG Therapeutics, Inc.

Biotechnology Research New York, Ny, United States 439 employees
Employees
439
Contacts
4
Emails
4
Phones
2

TG Therapeutics, Inc. Overview

Headquarters
New York, Ny, United States
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
439
Founded
2011
Funding
250.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About TG Therapeutics, Inc.

TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).

TG Therapeutics, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

TG Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Dawn Day
Email
Eric Roush
Email Phone
Janet Rose Director, Key Accounts, Neurology
Email Phone
Chris Bartony
Email

Employees by Management Level

Director 29 profiles
Individual contributor 15 profiles
Manager 12 profiles
Executive 4 profiles
VP / Head 2 profiles
Senior / Lead 1 profile
Intern / trainee 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 8 8 3
Executive 5 5 3
Marketing 5 5 3
Healthcare 5 4 4
Sales 4 4 2
Finance 3 3 1

TG Therapeutics, Inc. Tech Stack

Engineering 3 profiles
Data / AI 1 profile

Compare Similar Companies to TG Therapeutics, Inc.